Report of Foreign Issuer (6-k)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 or 15d-16
UNDER THE SECURITIES EXCHANGE ACT of 1934

 

For the Month of May 2018

 

001-37521

(Commission File Number)

 

INTEC PHARMA LTD.  

(Translation of registrant’s name into English)

 

12 Hartom Street

Har Hotzvim, Jerusalem 9777512, Israel  

(+972) (2) 586-4657  

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover

Form 20-F or Form 40-F.

 

Form 20-F ☒  Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(l): _________ 

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): _________ 

 

 

  

EXPLANATORY NOTE

 

On May 31, 2018, Intec Pharma Ltd. issued a press release titled “Intec Pharma to Present at Jefferies 2018 Healthcare Conference.”

 

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. 

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	INTEC PHARMA LTD.
	By:	/s/ Nir Sassi
		Name: Nir Sassi
		Title: Chief Financial Officer
Date: May 31, 2018

 

3

 

EXHIBIT INDEX

 

Exhibit No.	Description
99.1	Press Release, dated May 31, 2018

 

4